scispace - formally typeset
B

Bart C. Weimer

Researcher at University of California, Davis

Publications -  196
Citations -  9867

Bart C. Weimer is an academic researcher from University of California, Davis. The author has contributed to research in topics: Genome & Gene. The author has an hindex of 44, co-authored 181 publications receiving 8533 citations. Previous affiliations of Bart C. Weimer include North Carolina State University & Xiamen University.

Papers
More filters
Journal ArticleDOI

Comparative genomics of the lactic acid bacteria

TL;DR: Phylogenetic analyses, comparison of gene content across the group, and reconstruction of ancestral gene sets indicate a combination of extensive gene loss and key gene acquisitions via horizontal gene transfer during the coevolution of lactic acid bacteria with their habitats.
Journal ArticleDOI

Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens

TL;DR: The data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner, which suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.
Journal ArticleDOI

Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization Pathways

TL;DR: It is determined that the prominent neonate gut residents, Bacteroides thetaiotaomicron and Bactroides fragilis, induce the same genes during HMO consumption that are used to harvest host mucus glycans, which are structurally similar to HMOs.
Journal ArticleDOI

Isolation and characterization of acid- and bile-tolerant isolates from strains of Lactobacillus acidophilus

TL;DR: It is suggested that the isolated acid- and bile-tolerant isolates possess growth advantages over that of the parents under stress conditions and may be considered as candidates for probiotic strains after further characterization with animal models.
Journal ArticleDOI

Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

TL;DR: This work assessed the gene expression profile of C. difficile within the intestine of gnotobiotic mice to identify genes regulated in response to either dietary or microbiota compositional changes, and found that in the presence of the gut symbiont Bacteroides thetaiotaomicron, C.–difficiles induces a pathway that metabolizes the microbiota fermentation end-product succinate to butyrate.